Results 111 to 120 of about 4,590 (196)
Hypersensitivity reaction associated with subcutaneous glargine insulin therapy in a cat
Journal of Feline Medicine and Surgery Open Reports, 2016 Case summary A 14-year-old, domestic shorthair cat was treated for transient diabetes mellitus for 3 months with glargine insulin, which was discontinued when the diabetes mellitus resolved.
Lisa A Murphy +3 more
doaj +1 more source
Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens [PDF]
, 2003 Nuala Murphy +6 more
openalex +1 more source
Insulin glargine 300 U/mL safety data in pregnancy
Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2322-2325, May 2025.
Jukka Westerbacka +4 more
wiley +1 more source
Frontiers in PharmacologyBackgroundInsulin glargine is a long-acting drug and the first synthetic insulin to mimic human metabolism. The safety of insulin glargine in the real world remains to be further investigated.
Tongtong Wang +7 more
doaj +1 more source
An AI-enabled dual-hormone model predictive control algorithm that delivers insulin and pramlintide [PDF]
arXivCurrent closed-loop insulin delivery algorithms need to be informed of carbohydrate intake disturbances. This can be a burden on people using these systems. Pramlintide is a hormone that delays gastric emptying, which enables insulin kinetics to align with the kinetics of carbohydrate absorption.
arxiv
Journal of Health Economics and Outcomes Research, 2013 **Background:** Type 2 diabetes mellitus (T2DM) poses a significant burden on population well being and healthcare expenditure in Turkey, with disease prevalence continuing to increase.
Ilhan Satman +7 more
doaj +1 more source
Comparison of reaction networks of insulin signaling [PDF]
arXivUnderstanding the insulin signaling cascade provides insights on the underlying mechanisms of biological phenomena such as insulin resistance, diabetes, Alzheimer's disease, and cancer. For this reason, previous studies utilized chemical reaction network theory to perform comparative analyses of reaction networks of insulin signaling in healthy (INSMS:
arxiv
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
Качественная клиническая практика, 2018 Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin +5 more
doaj